Grant Pickering, Chief Executive Officer at Vaxcyte, sold PCVX on Jun 26, 2026
Data as of Oct 16
- Traded
- Jun 26, 2026
- Disclosed
- Jun 26, 2026
- Filed
- The same day
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
PCVX since disclosure
+12.6%
after the sale
Similar stocks (XLV) since disclosure
+10.2%
XLV — its sector index fund
Change in closing price from Jun 26, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLGrant Pickering Chief Executive OfficerPCVX Vaxcyte, Inc.$10.7Kdisclosed Jun 26 · filed the same day
- ▼ SELLGrant Pickering Chief Executive OfficerPCVX Vaxcyte, Inc.$11.2Kdisclosed Jun 26 · filed the same day
- ▼ SELLGrant Pickering Chief Executive OfficerPCVX Vaxcyte, Inc.$363Kdisclosed Jun 26 · filed the same day
- ▼ SELLGrant Pickering Chief Executive OfficerPCVX Vaxcyte, Inc.$505Kdisclosed Jun 26 · filed the same day
- ▼ SELLGrant Pickering Chief Executive OfficerPCVX Vaxcyte, Inc.$360Kdisclosed Jun 26 · filed the same day
- ▼ SELLGrant Pickering Chief Executive OfficerPCVX Vaxcyte, Inc.$19.7Kdisclosed Jun 26 · filed the same day
- ▼ SELLGrant Pickering Chief Executive OfficerPCVX Vaxcyte, Inc.$17Kdisclosed Jun 26 · filed the same day
- ▼ SELLGrant Pickering Chief Executive OfficerPCVX Vaxcyte, Inc.$18.6Kdisclosed Jun 26 · filed the same day